Using high-powered lasers, this new method could help biologists study the body’s immune responses and develop new medicines.

Chronic diseases like diabetes are prevalent, costly, and challenging to treat. A common denominator driving them may be a promising new therapeutic target.

By examining antigen architectures, MIT researchers built a therapeutic cancer vaccine that may improve tumor response to immune checkpoint blockade treatments.

New research reveals what it takes for a protein that is best known for protecting cells against death to take on the opposite role.

The findings suggest that biochemical and physical effects of exercise could help heal nerves.

By sidestepping the need for costly interventions, a new method could potentially reveal gene regulatory programs, paving the way for targeted treatments.

The drug-device combination developed by MIT spinout Lumicell is poised to reduce repeat surgeries and ensure more complete tumor removal.

MIT engineers’ new model could help researchers glean insights from genomic data and other huge datasets.

Membraneless organelles, also called biomolecular condensates, are changing how scientists think about protein chemistry, various diseases and even the origin of life.

A newly characterized anti-viral defense system in bacteria aborts infection through a novel mechanism by chemically altering mRNA.